LKLidiia Koludarova

Lidiia Koludarova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lidiia Koludarova has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Alina D. Nikotina

    Laboratory of Cell Protection Mechanisms, Institute of Cytology of Russian Academy of Sciences, St. Petersburg 194064, Russia

    1 shared publication
  • An-Sofie Lenaerts

    Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland

    1 shared publication
  • Arnaud Gaudin

    Queensland Brain Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Queensland, Australia

    1 shared publication
  • Ashley J. van Waardenberg

    I-Synapse PTY LTD, Cairns, Queensland, Australia

    1 shared publication
  • Boris A. Margulis

    Laboratory of Cell Protection Mechanisms, Institute of Cytology of Russian Academy of Sciences, St. Petersburg 194064, Russia

    1 shared publication
  • Brendan J. Battersby

    Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland

    1 shared publication

Latest Publications

  • Open Access

    DDHD2 provides a flux of saturated fatty acids for neuronal energy and function

    by Saber H. Saber, Nyakuoy Yak, Xuan Ling Hilary Yong, Yih Tyng Bong, Hannah Leeson, Chuan-Yang Dai, Tobias Binder, Siyuan Lu, Reshinthine Purushothaman, An-Sofie Lenaerts, et al.

    Although fatty acids support mitochondrial ATP production in most tissues, neurons are believed to rely exclusively on glucose for energy. Here we show that genetic ablation of the triglyceride and phospholipid lipase Ddhd2 impairs mitochondrial respiration and ATP synthesis in cultured neurons, despite increased glycolysis. This defect arises from reduced levels of long-chain saturated free fatty acids, particularly myristic, palmitic and stearic acids, normally released in an activity-dependent manner by Ddhd2. Inhibition of mitochondrial fatty acid import in wild-type neurons similarly reduced mitochondrial respiration and ATP production. Saturated fatty acyl-coenzyme A treatment restored mitochondrial energy production in Ddhd2 knockout neurons. When provided in combination, these activated fatty acyl-CoA supplements also rescued defects in membrane trafficking, synaptic function and protein homeostasis. These findings uncover that neurons perform β-oxidation of endogenous long-chain free fatty acids to meet ATP demands and reveal a potential therapeutic strategy for hereditary spastic paraplegia 54 caused by DDHD2 mutations.


  • Open Access

    Discovery and optimization of cardenolides inhibiting HSF1 activation in human colon HCT-116 cancer cells

    by Alina D. Nikotina, Lidia Koludarova, Elena Y. Komarova, Elena R. Mikhaylova, Nikolay D. Aksenov, Roman Suezov, Viktor G. Kartzev, Boris A. Margulis, Irina V. Guzhova

    Discovery and optimization of cardenolides inhibiting HSF1 activation in human colon HCT-116 cancer cells Discovery and optimization of cardenolides inhibiting HSF1 activation in human colon HCT-116 cancer cells